Stock Track | Arteris (AIP) Soars 11.20% After Hours on Strong Q3 Revenue and New Licensing Deal

Stock Track
Nov 05, 2025

Shares of Arteris, Inc. (NASDAQ: AIP) surged 11.20% in after-hours trading on Tuesday following the company's release of its third-quarter financial results and announcement of a significant licensing deal.

The semiconductor IP company reported quarterly revenue of $17.408 million, surpassing analyst expectations of $17 million. This represents an 18.32% increase compared to the same period last year. While Arteris posted an adjusted loss of $0.09 per share, in line with analyst estimates, investors appeared to focus on the company's top-line growth and future prospects.

Adding to the positive sentiment, Arteris announced a new licensing agreement with Altera, a major player in the FPGA market. The deal allows Altera to use Arteris' network-on-chip IP and system-on-chip integration automation software for developing next-generation FPGA and SoC FPGA solutions. This partnership is expected to enhance Altera's design productivity and performance across various applications, including data centers, communications, and aerospace.

The combination of better-than-expected revenue and the promising licensing deal with Altera seems to have fueled investor optimism, driving the significant after-hours stock price increase. As Arteris continues to expand its presence in the semiconductor IP market, investors will likely keep a close eye on the company's ability to convert these positive developments into sustained growth and profitability.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10